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Abstract
Background: Anxious parents have many concerns about the future health of their atopic infants.
Paediatricians and primary care practitioners need to seek knowledge on long-term outcomes in
order to cope with the increasing caseload of suspected allergy and the concerns of parents. The
aim of the study was to assess suspected and diagnosed allergy in infancy as predictors of allergy
and asthma in adolescence.
Methods: Families expecting their first baby and making their first visit to a maternity health care
clinic in 1986 were selected as the study population in a random sample. There were 1278 eligible
study families. The data were provided of the children at the ages of 9 and 18 months and 3, 5, 12,
15 and 18 years by health care professionals, parents, and adolescents (themselves).
Results: At the age of 9 months, the prevalence of allergy suspicions was distinctly higher than that
of allergy diagnoses. At the age of five years suspected allergy approaches were nil, and the
prevalence of diagnosed allergy was about 9%. During the adolescence, the prevalence of self-
reported allergy increases steadily up to the age of 18 years, and that of asthma remains at
approximately 5%. Suspected allergy at the age of 9 or 18 months and at the 5 years of age does
not predict allergy at adolescence. Compared with non-allergic children, children with definite
allergy at the age of 5 were over 8 times more likely to have allergy and nearly 7 times more likely
to have asthma in adolescence.
Conclusion: An early ascertained diagnosis of allergy, but not suspicions of allergy, predicts
prevailing allergy in adolescence. Efforts need to be focused on accurate diagnosis of early
childhood allergies.
Background
In recent years, the caseload related to suspected allergy
and symptoms perceived as allergic in primary care have
been increasing. Not all allergic symptoms persist, even
though a longitudinal study indicated a direct relation-
ship between childhood atopy and the development of
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asthma [1]. More severe atopy or atopy in early childhood
increase the risk of respiratory symptoms compared to
milder symptoms or later acquisition of atopy [2-4]. There
is a multitude of known potential risk factors for the per-
sistence or development of allergy and asthma [5]. Pre-
dicting occurrence of adult allergy and asthma in
childhood is a challenge [1,6].
In Finland the prevalence of early childhood atopic ecze-
mas (15–20%) is among the highest in the world [7]. Skin
symptoms related to atopic eczema are even much more
frequent (80%) [8]. Limited longitudinal follow-up data
from childhood to adulthood are available about allergic
diseases. Most prospective studies are short-term, with 2–
3 years of follow-up. A third of children less than 2 years
of age are suspected to have food allergy, but the majority
of the suspicions dissolve over the following year [9]. In
small children, the reported prevalence rate of atopic
allergy is 13–17% [10], of food allergy about 8% [11] and
of milk allergy about 2% [12,13]. One in three young
adults is atopic [14]. In a Finnish 32-year follow-up study,
the prevalence of adolescent asthma was 3–7%, and as
many had asthmatic symptoms [15]. Recently, when the
Finnish National Allergy Programme was launched [16],
one of its goals was to increase tolerance of mild symp-
toms in children, and focus the efforts on improving the
care of the more severe forms of the diseases.
The general aim of this study was to analyse the occur-
rence of suspected or diagnosed allergy and asthma from
birth to early adulthood. The specific aim was to deter-
mine the risk of having allergy or asthma in adolescence
after having diagnosed or suspected allergy at early child-
hood.
Methods
The present study is part of the Finnish Family Compe-
tence (FFC) Study started in 1985 in the Province of Turku
and Pori in South-Western Finland. Information was col-
lected on the lifestyle and health behaviour of young
Finnish families in order to further develop public health
service.
The study cohort was randomly selected from two of the
21 central hospital regions of the country. Two central
hospital regions were from South-Western Finland with a
total population of 713,000 (15% of the population of
Finland in 1985). Subject collection was based on strati-
fied randomised cluster sampling. For stratification, the
study area was divided into two parts, the southern area
(Turku University Hospital Region) and the northern area
(Satakunta Central Hospital Region). Each cluster con-
sisted of municipalities in the sample health authority
areas that did not differ significantly from all the other
municipalities in the province [17]. Randomisation was
carried out by selecting by lot 11 of the total of 35 health
authority areas weighted for stratum. All 67 maternity
health care clinics and 72 well-baby clinics of these 11
health authority areas participated in the study.
There is a public, countrywide network of well-baby clin-
ics in Finland. Practically every child is followed up at reg-
ular intervals in these clinics. After the check-ups of
midwife and neonatologist, the first visit to the well-baby
clinic is scheduled a couple of weeks after birth with sev-
eral regular follow-up visits during the first year of life.
Thereafter the frequency of routine visits is reduced to
once a year. The backbone of the well-baby clinics is the
public health nurse together with the physician who both
see the child and the family repeatedly.
Families expecting their first baby and having their first
visit to a maternity health care clinic in 1986 were selected
as the study population. About 99% of Finnish mothers
use public maternity health care clinic services [18]. In the
study area there were 1713 young families (i.e. nullipa-
rous women and their husbands) expecting their first
baby. Maternity health care nurses invited, according to
the instructions, 1582 women to participate, and 1443 of
them gave informed consent. The study subjects were
married or cohabiting couples or single women (n = 36,
2.5%). Of the invited, 139 (8.8%) refused to participate.
The occupational distribution of those who refused was
similar to that of the participants [16]. There were 1294
deliveries, of which three were stillbirths, eight children
died in infancy and five moved abroad. The number of the
eligible families was thus 1278. The number of eligible
study children was 1287, while seven women delivered
twins and one triplet. To assess the representativeness of
the results in the study population, several dropout anal-
yses were conducted. Young mothers (age at the begin-
ning of the study <20 years) (p < 0.02 in all study phases)
and mothers with nine years basic education (p < 0.01 at
18 months and 12 and 15 years) dropped out significantly
more often than others. No significant differences were
found in allergic findings between study children who
had complete data and those who dropped out. Hence,
the study results can be generalized to cover well the
whole study population.
Data were collected from early pregnancy to the children's
adolescence and adulthood, at first using questionnaires
to the parents at routine visits to the maternity health care
clinic during pregnancy, and thereafter at well-baby clin-
ics after the child's birth, at the ages of 9 and 18 months,
3 and 5 years. At the age 12, 15 and 18 years, the question-
naires were completed at the study families' homes. At the
ages of 9 and 18 months and 3 and 5 years, the data
obtained from the files of the well-baby clinics were used.
At the ages of 12, 15 and 18 years, the parents and chil-
dren independently filled in and returned the completed
questionnaires to the authors in sealed envelopes. FigureBMC Pediatrics 2009, 9:46 http://www.biomedcentral.com/1471-2431/9/46
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1 shows the numbers of participants of the consecutive
study phases. Furthermore, possible hospital care data
were utilized for the study.
At the beginning of the follow-up, the mean age of the
mothers was 25.4 years and that of the fathers 27.9 years.
One percent of the mothers had completed less than 9
years of basic education, the others at least 9 years of basic
education, and 42% of them had also completed 12 years
of education (9 years of basic education and 3 years of
upper secondary school).
Allergy and asthma in early childhood
The individual health records maintained at the well-baby
clinics were reviewed at the ages of 9 and 18 months, and
3 and 5 years, and categorized as follows: no allergy;
allergy suspected by a physician and allergy diagnosed by
a physician. The diagnosis was made by physicians (in
Finland, only qualified physicians make diagnoses),
recorded in the health record prospectively and the nurses
collected this data from the health records carefully. More-
over, the nurses gathering the data from the health records
were instructed to consider any such notes in the record
when classifying as allergy suspicions (rashes, eczemas
etc.).
Allergy and asthma in adolescence
When the children were 12, 15 and 18 years of age, ques-
tions about allergy and asthma included in the Achen-
bach's Child Behaviour Check List (CBCL) [19] and the
Youth Self Report (YSR) [20], were used. The parents and
the adolescents were asked independently if 1) the child
has allergy/I have allergy and 2) the child has asthma/I
have asthma. The responses were categorized as follows:
no fit (= unlikely allergy/asthma), some fit (possible
allergy/asthma) and good fit (= definite allergy/asthma).
The respondents were instructed to answer according to
whether the claim (e.g. I have asthma) does or does not fit
well to their particular situation. The agreement between
the answers of the parents and the children was fairly
good (the range of kappa coefficient values 0.5–0.8). The
present paper is based on the YSR data received from the
adolescents themselves.
Statistical methods
The difference in prevalence between boys and girls was
tested using the chi-squared test. The associations of diag-
nosed allergy (predictor variable) at the ages of 9 and 18
months, 3 and 5 years with definite self-reported allergy
or asthma (dependent variable) at the ages of 12, 15 and
18 years were analysed using binary logistic regression
with random intercept [21]. In the subject-specific model,
which takes into account the correlation between repeated
measurements at the ages of 12, 15 and 18 years, the
repeated measurements of the dependent variable (defi-
nite allergy or asthma vs unlikely allergy or asthma) were
analyzed using the same model. The predictive variable
was divided into two categories, diagnosed allergy or no
allergy. Separate models at different ages (9 and 18
months, 3 and 5 years) were used for the predictive varia-
ble. In addition, cumulative logistic regression was used
to analyse the association of allergy or asthma (diagnosed,
suspected or no allergy) at the ages of 9 and 18 months, 3
and 5 years with self-reported allergy or asthma (definite,
possible or unlikely) at the ages of 12, 15 and 18 years.
The results were quantified using odds ratios (ORs) or
cumulative odds ratios (CORs) with 95% confidence
intervals (95% CI). P-values lower than 0.05 were consid-
ered statistically significant. The analyses were done with
PROC GLIMMIX and PROC LOGISTIC of the SAS System
for Windows, release 9.1.3 (SAS Institute, Cary, NC, USA).
The study design was approved by the Ethical Committee
of the Turku University's Faculty of Medicine.
Results
The prevalence of suspected and diagnosed allergy in chil-
dren under 5 years of age according to the well-baby clinic
health records, and the prevalence of physician diagnosed
allergy are presented in Table 1. The prevalence of self-
reported allergy and asthma during adolescence are given
in Table 2. At the age of 9 months, the prevalence of
allergy suspicions was distinctly higher than that of allergy
diagnoses. There is a peak in the prevalence of suspected
allergy at 18 months and of diagnosed allergy in children
less than 3 years of age. At the age of five, the number of
suspected allergy approaches nil, and the prevalence of
diagnosed allergy is about 9%. There is a steadily growing
trend up to age 18 years in the self-reported prevalence of
allergy in adolescence. The prevalence of asthma is more
stable and stays approximately at the level of 5%.
The older the child the more accurately the diagnosed and
even suspected allergy predicts self-reported allergy in
adolescence (Table 3). Suspected allergy at 9 or 18 months
and at 5 years of age does not predict allergy in adoles-
cence. By contrast, the risk of allergy in adolescence is 2.9
– 4.1-fold if the child has been diagnosed as having allergy
at the age of 3 years and 3.4 – 6.3-fold with allergy diag-
nosed at the age of 5 years. Allergy diagnosis in childhood
tends to increase the risk of self-reported adolescent
asthma. Allergy suspicions in early childhood play no pre-
dictive role for adolescent asthma.
Figure 2 shows the individual risk of a definitely allergic
child to become an allergic or asthmatic adolescent. Anal-
ysis takes into account the correlation structure of the
repeated measurements, that is, whether the same child
who has allergy at 9 months, 18 months, 3 and 5 years has
allergy or asthma at the ages 12,15, and 18 years. It showsBMC Pediatrics 2009, 9:46 http://www.biomedcentral.com/1471-2431/9/46
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Study participants Figure 1
Study participants.
1443 mothers gave 
informed consent 
1112 nurses returned 
questionnaires 
1017 nurses returned 
questionnaires 
900 teenagers returned 
questionnaires 
908 parents returned 
questionnaires 
846 teenagers returned 
questionnaires 
745 parents returned 
questionnaires 
792 teenagers returned 
questionnaires 
787 parents returned 
questionnaires 
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questionnaires 
1030 nurses returned 
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that if a child has a diagnosis of allergy at the age of 5
years, there is a high risk of allergy (OR = 8.5, 95% CI 4.7
– 15.5) and asthma (OR = 6.7, 95% CI 3.3 – 13.8) at the
age of 18 years. This model also shows that the older the
child when allergy was diagnosed, the more accurately
this predicts allergy or asthma in adolescence.
Discussion
The main finding of this study was that suspected allergy
in early childhood does not predict later allergy diag-
noses. This stresses the importance of a careful diagnosis,
since definitely diagnosed, but not suspected allergy at the
ages 9 and 18 months and 3 and 5 years does predict
allergy at adolescence. This association becomes more
apparent the later the allergy diagnosis is confirmed. Diag-
nosed allergy at the age of 3 and 5 years even predicted
asthma in adolescence.
The original study population was highly representative of
the target population. Follow-up of the study sample was,
thanks to the good coverage of the Finnish maternity and
well-baby clinic network, very successful with good partic-
ipation rates throughout the study period [17]. Thus, the
validity of the study design can be considered very satis-
factory. The main limitation of this study is that the prev-
alence of adolescent allergy-like indicators and asthma
were based on adolescents' self-reports; however, with
repeated use of the same questionnaires. Since parents'
reports did not significantly differ from adolescents' self-
reports, self-reports were used. The presence or absence of
early childhood diagnoses of allergies and asthma were
based on the notes in the individual health records, from
where the data were collected by health care professionals.
The diagnoses were made by physicians. Testing the intra-
individual variability of different physicians in 72 well
baby clinics was not possible but they worked according
to the general diagnostic criteria of the time. Data collec-
tion was structured, systematic and the same methods
were used throughout as appropriate.
Consistent with the findings of other studies [1,22-26], we
found that an allergy diagnosis in childhood is a signifi-
cant risk factor for adolescent allergy and asthma. In the
present study, subjects with diagnosed allergy at the age of
5 years were over 8 times more likely to have allergy and
nearly 7 times more likely to have asthma than healthy
subjects. Of note is that suspected allergy before the age of
2 years had no significant effect on the prognosis of
allergy or asthma. However, a definite allergy diagnosed at
the age of 9 and 18 months significantly predicted the
occurrence of allergy at the age of 12 and 15 years but did
not significantly predict asthma at the same ages. Thus,
the risk of developing allergy or asthma in adolescence
was related to the age when a definite allergy was diag-
nosed. This could be connected with the previous finding
that the older the child the more reliable the food allergy
diagnosis [27]. Severe atopy in childhood has shown to be
a major determinant of the prognosis of allergic asthma in
adulthood [26]. The peak prevalence of suspected aller-
gies, about 14%, was seen at age less than 2 years, whereas
at age 5 years there were less than 1% suspected and 9%
diagnosed allergies.
Anxious parents have many concerns about the future
health of their atopic infants [28]. The well-baby clinic
professionals are at present dealing with increased public
awareness of allergic diseases and with recurrent queries
about very mild and passing symptoms [29]. The defini-
tion and diagnosis of allergies in early childhood remain
challenging because of lack of uniform criteria and avail-
ability of objective tests to support diagnosis. Mild aller-
gies, especially, constitute a diagnostic problem [29].
Table 1: The prevalence, n (%), of suspected allergy cases and diagnoses in children under 5 years of age reported by well-baby clinic 
nurses
Nurse-reported allergy 9 months
(n = 1234)
18 months
(n = 1030)
3 years
(n = 1112)
5 years
(n = 1017)
Suspected 151 (12.2) 142 (13.8) 104 (9.3) 8 (0.8)
Diagnosed 78 (6.3) 115 (11.2) 132 (11.9) 91 (8.9)
No allergy 1005 (81.5) 773 (75.0) 876 (78.8) 918 (90.3)
Table 2: The prevalence, n (%), of self-reported allergy and 
asthma during adolescence years
Self-reported allergy 12 years
n = 880
15 years
(n = 832)
18 years
(n = 785)
Possible 171 (19.4) 161 (19.3) 184 (23.4)
Definite 117 (13.3) 136 (16.4) 148 (18.9)
Unlikely 592 (67.3) 535 (64.3) 453 (57.7)
Self-reported astma 12 years
n = 891
15 years
n = 840
18 years
n = 789
P o s s i b l e 2 4( 2 . 7 )4 5( 5 . 4 )4 7( 6 . 0 )
Definite 51 (5.7) 44 (5.2) 42 (5.3)
Unlikely 816 (91.6) 751 (89.4) 700 (88.7)BMC Pediatrics 2009, 9:46 http://www.biomedcentral.com/1471-2431/9/46
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These clinical challenges will be tackled during the years
of the National Allergy Programme and much emphasis
will be put on accurate diagnosis [16]. Specifically, one
main goal is to halve the prevalence of elimination diets
by 2018. The results of the present study support the
notion of putting emphasis on accurately diagnosing early
childhood allergies, since suspicions without diagnosis do
not seem to indicate later allergologic problems. Most
children developing early atopic symptoms would not
have been considered having high atopy risk at birth [30].
The prevalence rates of suspected and diagnosed allergy in
early childhood years were in line with the results of pre-
vious studies [10]. During adolescent years, the preva-
lence of allergy increased from 13% at the age of 12 years
to 19% at the age of 18 years. These prevalence of allergy
confirm those from previous studies. The prevalence of
adolescent asthma, about 5%, is also concordant with pre-
vious results from Finland [7].
Conclusion
The clinical implications of the present results seem clear
and support the conclusions and lines of action of the
Table 3: Medically suspected and/or diagnosed allergy at the ages of 9 and 18 months, 3 and 5 years predictive of self-reported allergy 
and asthma at the ages of 12, 15 and 18 years.
Diagnosed allergy
Age Allergy 12 y
COR (95% CI)
15 y
COR (95% CI)
18 y
COR (95% CI)
9 months Suspected 1.4 (0.95 – 2.1) 1.4 (0.9 – 2.1) 1.5 (0.96 – 2.2)
Diagnosed 2.8 (1.7 – 4.7) 2.3 (1.4 – 3.9) 1.8 (1.1 – 3.2)
18 months Suspected 1.9 (1.3 – 2.8) 1.5 (0.96 – 2.2) 1.4 (0.96 – 2.2)
Diagnosed 1.9 (1.2 – 3.0) 1.7 (1.1 – 2.6) 1.3 (0.8 – 2.1)
3 years Suspected 1.9 (1.2 – 3.0) 2.0 (1.3 – 3.3) 2.0 (1.3 – 3.2)
Diagnosed 4.1 (2.3 – 6.1) 3.0 (2.0 – 4.6) 2.9 (1.9 – 4.4)
5 years Suspected 2.1 (0.6 – 8.1) 0.3 (0.0 – 2.6) 1.0 (0.2 – 4.5)
Diagnosed 6.3 (3.9 – 10.2) 4.1 (2.5 – 6.8) 3.4 (2.0 – 5.6)
Asthma
Age Allergy 12 y
COR (95% CI)
15 y
COR (95% CI)
18 y
COR (95% CI)
9 months Suspected 1.3 (0.7 – 2.6) 1.4 (0.7 – 2.7) 1.5 (0.8 – 2.7)
Diagnosed 2.5 (1.2 – 5.3) 2.1 (1.04 – 4.4) 2.0 (0.9 – 4.3)
18 months Suspected 1.9 (0.99 – 3.6) 1.7 (0.9 – 3.1) 1.6 (0.8 – 3.0)
Diagnosed 2.1 (1.02 – 4.2) 1.4 (0.7 – 2.9) 1.4 (0.7 – 3.0)
3 years Suspected 1.5 (0.7 – 3.5) 1.9 (0.9 – 3.8) 2.6 (1.2 – 4.4)
Diagnosed 4.7 (2.7 – 8.3) 3.3 (1.9 – 5.7) 2.8 (1.5 – 5.0)
5 years Suspected 1.9 (0.2 – 17.2) 3.5 (0.6 – 19.3) 3.2 (0.6 – 17.7)
Diagnosed 6.7 (3.7 – 12.2) 5.3 (3.0 – 9.5) 4.9 (2.7 – 8.9)
The analysis is based on logistic regression with random intercept (COR95%CI = cumulative odds ratio with 95% confidence intervals)BMC Pediatrics 2009, 9:46 http://www.biomedcentral.com/1471-2431/9/46
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Finnish Allergy Programme. Suspected allergies in the
early years of life do not pose a threat to the infants' future
well-being – and the need for accurate diagnostic proce-
dures is clear. Paediatricians and primary care profession-
als can reassure young families that allergy-type
symptoms most likely will pass, especially if they are mild.
Vice versa, with a definite diagnosis of allergy at the age of
5 the child will probably remain allergic or asthmatic in
his/her teens.
Abbreviations
CBCL: the Achenbach's Child Behaviour Check List; FFC:
the Finnish Family Competence Study; YSR: the Youth
Self Report.
Competing interests
The authors declare that we have no competing interests.
The authors have no institutional or corporate affiliations.
Authors' contributions
Pediatrician MK, a child allergologist, contributed to the
study design, the analysis and interpretation of data in the
prevention and progress of the allergies. Pediatrician PR,
as a specialist of epidemiological studies and preventive
medicine in well-baby clinic setting, made contributions
to the design, the acquisition of data, analysis, and inter-
pretation of data. Dr DHM, a specialist of primary health
care, contributed to the design, analysis, and interpreta-
tion of data. Biostatistician TV made contributions to the
design of the study and its' statistical analyses, and inter-
pretation of the statistical text. Pediatrician MA, a special-
ist of out-patient paediatrician, made contributions to the
epidemiological studies in the design, the acquisition of
data, analysis, and in the interpretation of data. A special-
ist of long term follow-up studies and epidemiological
studies, professor of child neurology MS made contribu-
tions to the design, the acquisition of data, analysis, and
interpretation of data. All authors have read and approved
the final manuscript.
Acknowledgements
Declaration of all sources of funding: Turku City Hospital has financially 
supported the work.
References
1. Rhodes HL, Sporik R, Thomas P, Holgate ST, Cogswell JJ: Early life
risk factors for adult asthma: A birth cohort study of subjects
at risk.  J Allergy Clin Immunol 2001, 108:720-725.
2. Peat JK, Salome CM, Sedgwick CS, Kerrebijn J, Woolcock AJ: A
prospecive study of bronchial hyperresponsiveness and res-
piratory symptoms in a population of Australian schoolchil-
dren.  Clin Exp Allergy 1989, 19:299-306.
3. Nickel R, Kulig M, Forster J, Bergmann R, Bauer CP, Lau S, Guggen-
moos-Holzmann I, Wahn U: Sensitisation to hen's egg at the age
of twelve months is predictive for allergic sensitisation to
common indoor and outdoor allergens at the age of three
years.  J Allergy Clin Immunol 1997, 99:613-617.
4. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan
WJ: Asthma and wheezing in the first six years of life.  N Eng J
Med 1995, 332:133-138.
5. Arshad SH: Primary prevention of asthma and allergy.  J Allergy
Clin Immunol 2005, 116:3-14.
6. Von Mutius E: Paediatric origins of adult lung disease.  Thorax
2001, 56:153-157.
7. The International Study of Asthma and Allergies in Childhood
(ISAAC) Steering Committee: Worldwide variation in preva-
lence of symptoms of asthma, allergic rhinoconjunctivitis,
and atopic eczema: ISAAC.  Lancet 1998, 351:1225-1232.
8. Lehtonen EP, Holmberg-Marttila D, Kaila M: Cumulative preva-
lence of atopic eczema and related skin symptoms in a well-
baby clinic: a retrospective cohort study.  Pediatr Allergy Immunol
2003, 14:405-408.
The subject-specific association of allergy at the ages of 9 and  18 months, 3 and 5 years with self-reported allergy, and  allergy (a) and asthma (b) at the ages of 12, 15 and 18 years Figure 2
The subject-specific association of allergy at the ages 
of 9 and 18 months, 3 and 5 years with self-reported 
allergy, and allergy (a) and asthma (b) at the ages of 
12, 15 and 18 years. In the subject-specific model, analysis 
takes into account the correlation structure of the repeated 
measurements, that is, whether a same child who has allergy 
at 9 months, 18 months, 3 and 5 years, has allergy (a) or 
asthma (b) at the ages 12,15, and 18 years. The predictive 
variable was divided into two categories, diagnosed allergy or 
no allergy at ages of 9 and 18 months, 3 and 5 years. The 
analysis is based on logistic regression with random inter-
cept, and the results are presented as Odds Ratios (OR) with 
95% Confidence Intervals.
16
a) 15
14
13
12
11
10
9
OR
8
7
6
5
4
3
2
1
9 months 5y e a r s 18 months 3 years 0
Age
b)
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
OR
9 months 5 years 18 months 3 years
AgePublish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Pediatrics 2009, 9:46 http://www.biomedcentral.com/1471-2431/9/46
Page 8 of 8
(page number not for citation purposes)
9. Eggesbo M, Halvorsen R, Tambs K, Botten G: Prevalence of paren-
tally perceived adverse reactions to food in young children.
Pediatr Allergy Immunol 1999, 10:122-132.
10. Vasar M, Julge K, Bjoksto B: Development of atopic sensitization
and allergic diseases in early childhood.  Acta Paediatr 2000,
89:523-527.
11. Bock SA: Prospective appraisal of complaints of adverse reac-
tions to foods in children during the first 3 years of life.  Pedi-
atrics 1987, 79:683-688.
12. Saarinen KM, Juntunen-Backman K, Järvenpää AL, Kuitunen P, Lope L,
Renlund M, Siivola M, Savilahti E: Supplementary feeding in
maternity hospitals and the risk of cow's milk allergy: a pro-
spective study of 6209 infants.  J Allergy Clin Immunol 1999,
104:457-461.
13. Host A: Frequency of cow's milk allergy in childhood.  Ann
Allergy Asthma Immunol 2002, 89:33-37.
14. Jogi R, Janson C, Björnsson E, Boman G, Björkstén B: Atopy and
allergic disorders among adults in Tartu, Estonia compared
with Uppsala, Sweden.  Clin Exp Allergy 1998, 28:1043-1046.
15. Huurre TM, Aro HM, Jaakkola JJ: Incidence and prevalence of
asthma and allergic rhinitis: a cohort study of Finnish adoles-
cents.  J Asthma 2004, 41:311-317.
16. Haahtela T, von Hertzen L, Mäkelä M, Hannuksela M, the Allergy Pro-
gramme working group: Finnish Allergy Programme 2008–2018
– time to act and change the course.  Allergy 2008, 63:634-645.
17. Rautava P, Sillanpää M: The Finnish Family Competence Study:
Knowledge of childbirth of nulliparous women seen at
maternity health care clinics.  Journal of Epidemiology and Commu-
nity Health 1989, 43:253-260.
18. Koskinen R, Meriläinen J, Gissler M, Virtanen M: Perinataalitilastot
(Finnish perinatal statistics).  Helsinki: STAKES; 1996. 
19. Achenbach T, Edelbrock C, Howell C: Empirically based assess-
ment of the behavioral/emotional problems of 2- and 3-year-
old children.  J Abnorm Child Psychol 1987, 15:629-650.
20. Achenbach T: Manual for the Youth Self Report and 1991 pro-
file.  Burlington: University of Vermont Department of Psychiatry;
1991. 
21. Molenberghs G, Verbeke G: Models for Discrete Longitudinal
Data.  Springer; 2005. 
22. Burrows B, Martinez FD, Halonen M, Barbee RA, Cline MG: Associ-
ation of asthma with serum IgE levels and skin-test reactivity
to allergens.  N Engl J Med 1989, 320:271-277.
23. Peat JK, Woolcock AJ: Sensitivity to common allergens: rela-
tion to respiratory symptoms and bronchial hyper-respon-
siveness in children from three different climactic areas of
Australia.  Clin Exp Allergy 1991, 21:573-581.
24. Xuan W, Marks GB, Toelle BG, Belousova E, Peat JK, Berry G, Wool-
cock AJ: Risk factors for onset and remission of atopy,
wheeze, and airway hyperresponsiveness.  Thorax 2002,
57:104-109.
25. Koh YY, Kim CK: The development of asthma in patients with
allergic rhinitis.  Curr Opin Allergy Clin Immunol 2003, 3:159-164.
26. Limb SL, Brown KC, Wood RA, Wise RA, Eggleston PA, Tonascia J,
Hamilton RG, Adkinson NF Jr: Adult asthma severity in individ-
uals with a history of childhood asthma.  J Allergy Clin Immunol
2005, 115:61-66.
27. Kajosaari M: Food allergy in Finnish children aged 1 to 6 years.
Acta Paediatr Scand 1982, 71:815-819.
28. Arvola T, Tahvanainen A, Isolauri E: Concerns and expectations
of parents with atopic infants.  Pediatr Allergy Immunol 2000,
11:183-188.
29. Johnke H, Vach W, Norberg LA, Bindslev-Jensen C, Host A,
Andersen KE: A comparison between criteria for diagnostic
atopic eczema in infants.  Brit J Dermatol 2005, 153:352-358.
30. Bergmann RL, Edenharter G, Bergmann KE, Guggenmoos-Holzmann
I, Forster J, Bauer CP, Wahn V, Zepp F, Wahn U: Predictability of
early atopy by cord blood IgE and parental history.  Clin Exp
Allergy 1997, 27:752-760.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2431/9/46/prepub